MINNEAPOLIS/ST. PAUL (08/20/2024) — Published in JCI Insight, a research team led by the University of Minnesota Medical School has identified small molecules that can reduce the production of ...
A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO) ...
In a regulatory filing, the company stated: “LENZ Therapeutics (LENZ) is aware of a recent adverse event report submitted to the U.S. Food and Drug Administration’s Adverse Event Reporting System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results